EP1625401A1 - Vorrichtung und verfahren zum erkennen der anwesenheit eines luftgebundenen mycotoxins in einer einschliessung - Google Patents

Vorrichtung und verfahren zum erkennen der anwesenheit eines luftgebundenen mycotoxins in einer einschliessung

Info

Publication number
EP1625401A1
EP1625401A1 EP03741800A EP03741800A EP1625401A1 EP 1625401 A1 EP1625401 A1 EP 1625401A1 EP 03741800 A EP03741800 A EP 03741800A EP 03741800 A EP03741800 A EP 03741800A EP 1625401 A1 EP1625401 A1 EP 1625401A1
Authority
EP
European Patent Office
Prior art keywords
set forth
mycotoxin
medium
air
liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03741800A
Other languages
English (en)
French (fr)
Other versions
EP1625401A4 (de
Inventor
D. C. Dept. of Microbiology & Immunology STRAUS
S. C. Dept. of Microbiology & Immunology WILSON
T. L. Dept. of Microbiology & Immunology BRASEL
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Assured Indoor Air Quality LP
Original Assignee
Assured Indoor Air Quality LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assured Indoor Air Quality LP filed Critical Assured Indoor Air Quality LP
Publication of EP1625401A1 publication Critical patent/EP1625401A1/de
Publication of EP1625401A4 publication Critical patent/EP1625401A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/02Devices for withdrawing samples
    • G01N1/22Devices for withdrawing samples in the gaseous state
    • G01N1/2202Devices for withdrawing samples in the gaseous state involving separation of sample components during sampling
    • G01N1/2205Devices for withdrawing samples in the gaseous state involving separation of sample components during sampling with filters
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/24Methods of sampling, or inoculating or spreading a sample; Methods of physically isolating an intact microorganisms
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56961Plant cells or fungi
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/02Devices for withdrawing samples
    • G01N1/22Devices for withdrawing samples in the gaseous state
    • G01N1/2273Atmospheric sampling
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40Concentrating samples
    • G01N1/405Concentrating samples by adsorption or absorption
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40Concentrating samples
    • G01N1/4077Concentrating samples by other techniques involving separation of suspended solids
    • G01N2001/4088Concentrating samples by other techniques involving separation of suspended solids filtration
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/37Assays involving biological materials from specific organisms or of a specific nature from fungi

Definitions

  • This invention relates to an apparatus for and method of detecting an airborne mycotoxin in an enclosure and, more especially, an apparatus for and method of detecting an airborne trichothecene in a building.
  • Mycotoxins are chemical substances produced by fungi.
  • trichothecenes are known to be produced by a number of different fungi, such as Stachybotxys sp. and Fusarl ⁇ m sp.
  • Stachybotxys sp. and Fusarl ⁇ m sp.
  • Anguidine a type A trichothecene preparation called "Anguidine” was injected into humans.
  • the subjects developed central nervous system and dermal disorders as well as other disorders. These symptoms are similar to those reported by occupants of mold contaminated buildings. It must be noted, however, that many factors can contribute to these symptoms.
  • SBS Sick Building Syndrome
  • Fungi and their secondary metabolites; such as, mycotoxins have been areas that have been closely examined. Fungi and their spores are known human allergens, especially in sensitized individuals. Fungi isolated from sick buildings include a wide variety of genera and species. It is logical to hypothesize that fungi growing indoors have been introduced from the outside. The fungi eventually find an effective growth niche consisting of water and an appropriate food source. The end result is an undesirable high concentration of fungal effluents. Of particular importance is that highly respirable fungal fragments are aerosolized simultaneously with spores in amounts as high as 320 times that of spores . These fungal fragments could be potential carriers of mycotoxins.
  • SC Stachybotrys chartarvm
  • an apparatus for detecting the presence of an airborne mycotoxin in an enclosure Pumping apparatus draws a portion of environmental air from the enclosure. A medium is disposed to receive the portion of the environmental air and to separate mycotoxins from the portion of air. Testing apparatus is then used to determine the presence of mycotoxins separated from the portion of air.
  • a method of detecting the presence of an airborne mycotoxin in an enclosure comprises the steps of continually removing a portion of environmental air from a chosen area in the enclosure. The portion of environmental air is then passed through a filtering medium. Any filtrate filtered from the air is tested to determine the presence of a mycotoxin.
  • FIG. 1 illustrates an apparatus for and a method of detecting the presence of an airborne mycotoxin in an enclosure or a building.
  • FIG. 1 there is shown an apparatus 10 for and a method of detecting the presence of an airborne mycotoxin in an enclosure or building.
  • a pumping apparatus 12 is used to draw a portion of the environmental air, as represented by arrow 14, from a location in the building or other enclosure and a filter medium 16 is disposed to receive the portion of the environmental air 14 and to separate and trap the airborne mycotoxins from the portion of air 14.
  • the filtered air portion, as represented by arrow 18, may then be returned to the building or exhausted outside of the building.
  • pumping apparatus 12 and filter medium 16 are shown as separate apparatus, they may be combined in a single housing and disposed within a single room of a residential house.
  • the filter medium 16 may be a conventional electrostatic filter or may be made of particulate matter having a liquid provided on the surface of the particulate matters to absorb the mycotoxin while the air is flowing through the filter.
  • a unitized machine that has been found to provide acceptable results is the DeLonghi DAP 130 Air Purifier with electrostatic filters manufactured for this machine.
  • this machine When this machine is used, it is normally operated at its "high” setting with the ionizer on and the filters collecting airborne particles. Normally, the "high" setting provides a flow rate of about 8000 liters per minute and has lower settings to provide lower flow rates. Thus, the machine has flow rates up to about 80Q0 liters per minute. To insure sufficient environmental air is passed through filter medium 16 to obtain a competent test, it has been determined that the collection time take up to 24 hours and this 24 hour period may extend up to 7 days.
  • Filter medium 16 is submerged in lOOOmL of pyrogen free water in a sterilized glass beaker 20 capable of containing this amount of volume. Beaker 20 with submerged filter is then placed in distilled water and a sonic cleaning apparatus 22 is used separate the particulate matter from filter medium 16.
  • a sonic cleaning apparatus 22 is used separate the particulate matter from filter medium 16.
  • beaker 20 is removed from ultrasonic cleaner 22 and allowed to sit at a room temperature of about 25°C between 18 and 24 hours.
  • the filter medium 16 is removed from the water extract and squeezed to remove any absorbed water where it is collected in beaker 20.
  • the filter extract is passed through sterilized Nalgene Reusable Filter Holders (Fisher Scientific Catalog number 09-740-23E) incorporating Whatman (Cat. No. 7402-004) 0.2 ⁇ m, 47mm nylon membrane filters.
  • the cleanup filtrate 24 is accomplished using an in house vacuum operating at a flow rate of about 65 liters per minute.
  • the cleanup filtrate is divided in two with each part being placed into VirTis 1200mL lyophilization jars. These samples were frozen using a rotating ethanol bath at -70°C on the Virtis Freezemobile. After the samples are frozen, they are lyophilized to dryness in the same machine, which incorporates a Fisher Scientific Maxima C Plus Model M6C vacuum pump. The two dried samples are suspended and combined in lOmL of a total pyrogen free water. The lOmL of concentrated filter extract 26 is again filtered. This time by being passed through Millex-GP 0.22pm Millipore sterilized syringe filters. The syringes used are Beaton Dickinson lOcc Luer SLIP TIP syringes.
  • the final filtrate 26 is the working sample used in a conventional enzyme linked xmmunosorbent assay (" ⁇ LISA”) , such as that sold by "QuantiToxTM Trichothecenes Plate Kit. " This assay is manufactured by EnviroLogix of 500 Riverside Industrial Parkway, Portland ME 04103-1418. It is believed that this test kit uses the apparatus and monoclonal antibodies disclosed in U.S. Pat. No. 4,772,551.
  • ⁇ LISA enzyme linked xmmunosorbent assay
  • each well is rinsed five times with 300 ⁇ l of the phosphate buffered saline solution.
  • the plate is then slapped on a paper towel to remove as much water as possible.
  • 100ml of the substrate provided with the kit is added to each well.
  • the contents of the wells are thoroughly mixed.
  • the wells are covered with new tape or Parafilm and incubated for 15 minutes at ambient temperature.
  • 100ml of a Stop Solution provided with the kit is added to the wells. The solution is then read at 450nm.
  • ELISA inhibition rates ranged from 35.5% to 95.0% compared to controls.
  • the presence of macrocyclic trichothecenes was confirmed using a modified Andersen Polyurethane Foam High Volume Air Sampler in one residence. Sampling times were 24, 48, and 72 hours.
  • ELISA inhibition rates ranged from 70.0 to 79.1% with the first stage filters and increased significantly over time (27.1 to 49.4%) on the second stage filters.
  • EXAMPLE I The first building selected was an unoccupied house that contained personal belongings. Two rooms were chosen for testing, the living room and the utility room. The living room had no visible fungal growth and was open to the rest of the house. The utility room was documented to have a leak from the water heater and was an enclosed area. Fungal growth was visible and was confirmed to be Stachybotrys chartarum (SC) .
  • SC Stachybotrys chartarum
  • the second building selected was an unoccupied house that contained personal belongings .
  • An enclosed closet was chosen for testing. This was a storage closet in the garage. Fungal contamination was visible. SC was confirmed among other organisms.
  • a DeLonghi DAP 130 Air Purifier with an electrostatic filter in place was set at high was positioned at floor level in the storage closet. The purifier was operated at environmental temperatures and pressures. Air conditioning was turned off and never on in the houses during testing. Even though the purifier came equipped with pre-filters for large particles, the pre- filters were removed before testing began. The purifier ran for one week. The electostatic filters were removed from the machine and handled in accordance with the procedure previously described. After the final filtrates were obtained, they were processed in accordance with the procedure relating to the ALISA previously described to indicate the presence of a trichothecene (a mycotoxin) within the building.
  • EXAMPLE III The third building selected was a house that was occupied, but the room chosen for testing was enclosed and remained closed to the rest of the house. The room was a bathroom. Fungal contamination was visible in the shower. SC was confirmed among other organisms.
  • a DeLonghi DAP 130 Air Purifier with an electrostatic filter in place was set at high and positioned at about two feel above floor level in the bathroom. The purifier was operated at environmental temperatures and pressures . Air conditioning was not turned off. Even though the purifier came equipped with pre-filters for large particles, the pre-filters were removed before testing began. The purifier ran for one week. The electostatic filters were removed from the machine and handled in accordance with the procedure previously described.
  • EXAMPLE IV The fourth building selected was an unoccupied house that contained personal belongings .
  • Four rooms were chosen for sampling - the living room, TV room, upstairs bedroom, and kitchen. No room was entirely closed off to the rest of the house.
  • the living room was sampled for 24 hours with the purifier being at floor level.
  • the other three rooms were sampled for one week with the purifier in the TV room being elevated above floor level by about 3.5 feet, the purifier in the upstairs bedroom being elevated above the floor level by about two feet and the purifier in the kitchen being at floor level.
  • Fungal contamination was clearly evident in all pf the rooms.
  • the kitchen showed the heaviest fungal growth. SC was confirmed among other organisms.
  • a DeLonghi DAP 130 Air Purifier with an electrostatic filter in place was operated at environmental temperatures and pressures.
  • the fifth building selected was an unoccupied house that contained no personal belongings.
  • Four rooms were chosen for sampling - the main entry room, the back entry room, the kitchen, and a bedroom.
  • the house was open to the outside environment (much of the roof was not present, only covered by a tarp, and some of the floor had been removed and exposed to the foundation) so environmental conditions most likely varied. These, however, were not measured.
  • the chosen bedroom was sampled for 24 hours at floor level.
  • the main and back entry rooms were sampled for one week at floor level.
  • the kitchen was sampled for one week at an elevation of about 4 feet above floor level. No room was closed off to the rest of the house. Fungal contamination was clearly evident throughout the house, the worst being the kitchen. SC was confirmed.
  • a DeLonghi DAP 130 Air Purifier with an electrostatic filter in place was operated at environmental temperatures and pressures at each of the speci ied locations for the specified periods of time. Even though the purifier came equipped with pre- filters for large particles, the pre-filters were removed before testing began. The purifier in the corner room ran for 24 hours and the remaining purifiers ran for one week. The electrostatic filters were removed from the machine and handled in accordance with the procedure previously described. After the final filtrates were obtained, they were processed in accordance with the procedure relating to the ALISA previously described to indicate the presence of trichothecene (a mycotoxin) within the building.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Filtering Materials (AREA)
EP03741800A 2003-05-12 2003-05-12 Vorrichtung und verfahren zum erkennen der anwesenheit eines luftgebundenen mycotoxins in einer einschliessung Withdrawn EP1625401A4 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2003/014856 WO2004106933A1 (en) 2003-05-12 2003-05-12 Apparatus for and method of detecting the presence of and airborne mycotoxin in an enclosure

Publications (2)

Publication Number Publication Date
EP1625401A1 true EP1625401A1 (de) 2006-02-15
EP1625401A4 EP1625401A4 (de) 2006-09-06

Family

ID=33488751

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03741800A Withdrawn EP1625401A4 (de) 2003-05-12 2003-05-12 Vorrichtung und verfahren zum erkennen der anwesenheit eines luftgebundenen mycotoxins in einer einschliessung

Country Status (3)

Country Link
EP (1) EP1625401A4 (de)
AU (1) AU2003304160A1 (de)
WO (1) WO2004106933A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240151613A1 (en) * 2021-03-13 2024-05-09 Goldsworthy, Robert Method for extraction of mycotoxins from a sample

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5178832A (en) * 1987-09-28 1993-01-12 The Texas A&M University System Selective immobilization and detection of mycotoxins in solution
US4954320A (en) * 1988-04-22 1990-09-04 The United States Of America As Represented By The Secretary Of The Army Reactive bed plasma air purification
ITPN940015A1 (it) * 1994-03-16 1995-09-16 Procond Elettronica Spa Depuratore d'aria a filtro elettrostatico

Also Published As

Publication number Publication date
WO2004106933A1 (en) 2004-12-09
EP1625401A4 (de) 2006-09-06
AU2003304160A1 (en) 2005-01-21

Similar Documents

Publication Publication Date Title
Luczynska et al. Airborne concentrations and particle size distribution of allergen derived from domestic cats (Felis domesticus)
Straus Molds, mycotoxins, and sick building syndrome
Blachere et al. Sampling and characterization of bioaerosols
Kim et al. Airborne bioaerosols and their impact on human health
Mølhave et al. House dust in seven Danish offices
Habenicht et al. Allergen carriage by atmospheric aerosol: II. Ragweed-pollen determinants in submicronic atmospheric fractions
Croft et al. Airborne outbreak of trichothecene toxicosis
Wålinder et al. Nasal lavage biomarkers: effects of water damage and microbial growth in an office building
Nelson et al. Recommendations for the use of residential air-cleaning devices in the treatment of allergic respiratory diseases
Rask-Andersen et al. Endotoxin levels in farming: absence of symptoms despite high exposure levels.
WO2003081212A2 (en) Adjustable air sampler with psychrometrics for viable and non-viable aerosols
Venaille et al. Cell recruitment into lung wall and airways of conventional and pathogen-free guinea pigs after inhalation of endotoxin.
Kawai et al. Precipitating antibodies against organic dust antigens in human sera by counterimmunoelectrophoresis
Olenchock et al. Endotoxins in cotton: washing effects and size distribution
CN107764987A (zh) 一种空气净化器去除尘螨抗原效果的检测方法
Heikkinen et al. Bioaerosols
US20050208606A1 (en) Apparatus for and method of detecting the presence of an airborne mycotoxin in an enclosure
Clausen et al. Development of sensitisation or tolerance following repeated OVA inhalation in BALB/cJ mice. Dose-dependency and modulation by the Al (OH) 3 adjuvant
Kujundzic et al. Effects of ceiling-mounted HEPA-UV air filters on airborne bacteria concentrations in an indoor therapy pool building
EP1625401A1 (de) Vorrichtung und verfahren zum erkennen der anwesenheit eines luftgebundenen mycotoxins in einer einschliessung
Nelson et al. How ill the wind? Issues in aeroallergen sampling
Singh et al. Influence of home characteristics on airborne and dustborne endotoxin and β-D-glucan
Macher et al. 12 Bioaerosols
Holmquist et al. Airborne birch and grass pollen allergens in street-level shops.
Anderson et al. Sump bay fever: inhalational fever associated with a biologically contaminated water aerosol.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20051212

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20060803

17Q First examination report despatched

Effective date: 20070226

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070709